Skip to main content

stock

CTMX · CytomX Therapeutics, Inc.

What CytomX Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live CTMX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CTMX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
217,899,284 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-476.2%
Net
-435.2%

Returns

ROE
-26.4%
ROA
-20.9%

Health

Current ratio
9.4x
Debt/equity
—

Deep value

NCAV
$294.00M
NCAV per share
$1.35
Price/NCAV
Locked
NNWC
-$33.81M
NNWC per share
-$0.16
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$1.42M—Gross profit: unreported by this company.-$23.78M-$20.67M
10-Q filed 2026-08-06
2026-03-31$10.26M—Gross profit: unreported by this company.-$19.67M-$18.25M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$663,000—Gross profit: unreported by this company.-$27.93M-$26.51M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$5.96M—Gross profit: unreported by this company.-$15.77M-$14.23M
10-Q filed 2025-11-06
2025-06-30$18.66M—Gross profit: unreported by this company.-$1.29M-$154,000
10-Q filed 2026-08-06
2025-03-31$50.92M—Gross profit: unreported by this company.$22.62M$23.52M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$38.09M—Gross profit: unreported by this company.$17.68M$18.88M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$33.43M—Gross profit: unreported by this company.$4.11M$5.74M
10-Q filed 2025-11-06
Assets
$381.23M
Equity
$302.07M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$76.20M-$22.36M-$17.37M-$75.81M
2024-12-31$138.10M$25.00M$31.87M-$86.54M
2023-12-31$101.21M-$6.48M-$569,000-$56.88M
2022-12-31$53.16M-$101.33M-$99.32M-$112.53M
2021-12-31$37.31M-$116.04M-$115.87M-$120.64M
2020-12-31$68.43M-$80.54M-$64.82M$2.95M
2019-12-31$26.90M-$141.48M-$132.82M-$143.98M
2018-12-31$59.50M-$77.87M-$84.60M-$79.31M
2017-12-31$71.62M-$46.26M-$43.10M$168.81M
2016-12-31$12.85M-$59.59M-$58.90M-$4.21M

Company filings

since Mon Mar 16 · 2 offering filings in 12 months · since Wed Mar 18

events

  • Results

    Results
    Aug 68-K
  • Executive or director change

    Executive or director change
    Jul 278-K
  • Executive or director change, Bylaws or fiscal year change, Shareholder vote results

    Executive or director changeBylaws or fiscal year changeShareholder vote results
    Jun 228-K
  • Material agreement

    Material agreement
    Jun 38-K
  • Results

    Results
    May 78-K
  • Other event

    Other event
    Mar 198-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

Funds

News

Stories that named CTMX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about CTMX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about CTMX.

nakagai

Signals on CTMX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CTMX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

CytomX Therapeutics, Inc. (CTMX): SEC filings, financials and insider trades · Nakagai